PA 344 / PA 344B

Drug Profile

PA 344 / PA 344B

Alternative Names: DCK compounds; PA-344; PA-344B

Latest Information Update: 17 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of North Carolina
  • Class Antiretrovirals; Coumarins
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 15 Mar 2005 Panacos Pharmaceuticals has been acquired and merged into V.I. Technologies
  • 12 Dec 2002 A preclinical study has been added to the pharmacokinetics and Viral Infections pharmacodynamics sections
  • 01 Aug 2002 A study has been added to the Viral Infections antimicrobial activity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top